Company Overview and News

Brazil BRF board supports candidate list

2018-04-20 reuters
SAO PAULO, April 20 (Reuters) - The board of Brazilian food company BRF SA has endorsed a list of 10 candidates ahead of a vote on a new set of directors, the company said on Friday, suggesting top shareholders have reached a consensus on its composition.
Upvote Downvote

Carney Takes on Markets With Shock Warning on BOE Rate View - Bloomberg

2018-04-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

UPDATE 1-Shareholder of Brazil's BRF says board battle hurting business

2018-04-17 reuters
SAO PAULO (Reuters) - A major shareholder in embattled food processor BRF SA said on Tuesday that talks among investors to agree on candidates for the company’s board have stalled, with a prolonged leadership struggle damaging plans for a turnaround.
Upvote Downvote

UPDATE 1-Controlling shareholder in Magazine Luiza to run for BRF´s board

2018-04-17 reuters
SAO PAULO, April 17 (Reuters) - Luiza Helena Trajano, controlling shareholder in Brazilian appliance retailer Magazine Luiza SA, is one of the candidates to join poultry exporter BRF SA´s board, according to documents related to the board election.
Upvote Downvote

UPDATE 1-New board of Brazil's BRF likely to keep top executives -sources

2018-04-16 reuters
SAO PAULO, April 16 (Reuters) - Executives at Brazilian food processor BRF SA are likely to stay in charge after a new board is elected this month, three people close to the matter said, in a sign of confidence from key shareholders that they can pull off a turnaround at the struggling food company.
Upvote Downvote

Why the U.K. Won't Punish Russia by Going After Its Debt Markets - Bloomberg

2018-03-29 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote


2018-03-20 globenewswire
PURCHASE, N.Y., March 20, 2018 (GLOBE NEWSWIRE) -- Each of Alpine Total Dynamic Dividend Fund (NYSE: AOD), Alpine Global Dynamic Dividend Fund (NYSE: AGD) and Alpine Global Premier Properties Fund (NYSE: AWP) (each, a “Fund” and collectively, the “Funds”) announced today that at the Special Meetings of Shareholders of the Funds held on Wednesday, March 14, 2018, shareholders approved a new investment advisory agreement with Aberdeen Asset Managers Limited (“AAML”) (and for AWP, also a subadvisory agreement with Aberdeen Asset Management Inc.
Upvote Downvote

Credit Suisse Tries to Lure Investors With Invite-Only K-Pop Concert - Bloomberg

2018-03-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Prudential unveils radical overhaul as it splits itself in two FTSE 100 firms

British insurance giant Prudential has unveiled a radical overhaul that will see it split its UK and European businesses from its international ones.
Upvote Downvote

Prudential to split in new world order for British insurers - Channel NewsAsia

2018-03-14 channelnewsasia
LONDON: Prudential is to spin off its British and European business from its international operations, breaking up the 170-year-old insurer to refocus on faster-growing markets in the sector's latest major shake-up.
Upvote Downvote

UPDATE 1-Federated Investors in talks to take stake in fund manager Hermes - sources

2018-03-01 reuters
LONDON (Reuters) - U.S. fund manager Federated Investors (FII.N) has entered exclusive talks with Hermes Investment Management about buying a controlling stake in Hermes, sources familiar with the matter said on Thursday.
Upvote Downvote

Standard Life Aberdeen confirms £3bn insurance sale 

Standard Life Aberdeen is selling its insurance business to smaller rival Phoenix Group in a deal worth £3.2bn. 
Upvote Downvote

Standard Life Aberdeen starts chairman search as Sir Gerry eyes exit  

Standard Life Aberdeen has pressed the firing gun on its search for a new chairman as Sir Gerry Grimstone prepares to step down from the group. 
Upvote Downvote

Pressure rises on Standard Life Aberdeen ahead of £30bn blow

Investors have pulled more than £30bn out of Standard Life Aberdeen funds in just 12 months, the embattled asset manager is expected to reveal this week amid speculation it could boost its dividend to soften the impact.
Upvote Downvote

Trick to Selling Hedge Funds Is Calling Them Anything Else - Bloomberg

2018-02-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 00300A104